Search for: "Wyeth Pharmaceuticals"
Results 1 - 20
of 978
Sort by Relevance
|
Sort by Date
2 Apr 2024, 9:50 am
[If doctors cannot sue the FDA for failing to restrict pharmaceuticals or other products, can anyone else? [read post]
1 Apr 2024, 6:18 am
Wyeth Pharmaceuticals, Inc., 616 F.3d 134 (2d Cir. 2010), that a plaintiff is not required to prove the employer's articulated reason is false, and that the the plaintiff can prevail by showing that an unlawful factor (like sex, race, etc.) was a motivating factor, even "without proving that the employer's proffered explanation was not some part of the employer's motivation. [read post]
8 Dec 2023, 7:58 am
Wyeth and Idenix demand full scope enablement, and structural details have been necessary in life science genus [read post]
28 Nov 2023, 5:24 am
., 487 U.S. 500 (1988) Wyeth v. [read post]
19 Sep 2023, 8:32 am
Wyeth LLC v. [read post]
12 Sep 2023, 9:42 am
Pharmaceutical startups and those in the tech industry have been among those most reported. [read post]
8 Jun 2023, 7:43 am
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
8 Jun 2023, 7:43 am
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
6 Apr 2023, 6:38 am
The judge reviewed the national case law on selections/deletions from multiple lists (Merck v Shionogi [2016] EWHC 2989 (Pat), Nokia v IPCom [2012] EWCA Civ 567 and GlaxoSmithKline v Wyeth [2016] EWHC 1045 (Pat)) and the EPO cases reviewed therein and in the EPO Case Law Book. [read post]
31 Jan 2023, 6:36 pm
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
19 Mar 2022, 2:09 pm
Risk assessments would seemingly be about assessing risks, but they are not. [read post]
30 Jun 2021, 3:35 pm
Wyeth, 85 A.3d 434 (Pa. 2014). [read post]
17 May 2021, 12:45 am
MSD / Wyeth, District Court of The Hague 11 November 2020 (Judges Kokke, Aalbers and Schüller) [Dutch decision here]In a second decision on auxiliary requests in a case between pharmaceutical companies MSD and Wyeth, the District Court – in a panel with two of the same judges as in the Biogen/Richter case – decided along the same lines as the Biogen/Richter case with regard to the scope of the validity debate after (unconditional) auxiliary… [read post]
13 May 2021, 11:45 am
The SPC application was filed by Wyeth and the General Hospital Corporation on the basis of European patent No. [read post]
23 Dec 2020, 5:31 am
The main course – Supreme Court cases (7) Modified Mouse Surprise In Regeneron Pharmaceuticals v Kymab [2020] UKSC 27, the UK Supreme Court reviewed the principle of general application in relation to Regeneron’s patents for the creation of a range of types of transgenic mice that produce chimeric antibodies. [read post]
29 Jun 2020, 12:41 pm
Wyeth Pharmaceuticals, Inc., U.S. [read post]
13 May 2020, 2:03 am
Wyeth, 738 F. [read post]
9 Aug 2019, 2:59 am
Wyeth Go Wrong” [Dorit Reiss, Petrie-Flom “Bill of Health”] “Drug lawsuit ads are scaring seniors to death” [P. [read post]
23 May 2019, 9:30 pm
Supreme Court ruled that judges rather than juries should determine whether or not pharmaceutical product liability claims may proceed under the “clear evidence” standard established in Wyeth v. [read post]
21 May 2019, 6:18 am
A decade ago in Wyeth v. [read post]
